Imaging biomarkers of angiogenesis and the microvascular environment in cerebral tumours
Authors:
- S J MillsSMS J Mills
- D J CoopeDCD J Coope
- J P B O’cOnnorJOJ P B O’cOnnor
- A JacksonAJA Jackson
- 1 December 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 84 (special__2) , S127-S144
Abstract
Conventional contrast-enhanced CT and MRI are now in routine clinical use for the diagnosis, treatment and monitoring of diseases in the brain. The presence of contrast enhancement is a proxy for the pathological changes that occur in the normally highly regulated brain vasculature and blood-brain barrier. With recognition of the limitations of these techniques, and a greater appreciation for the nuanced mechanisms of microvascular change in a variety of pathological processes, novel techniques are under investigation for their utility in further interrogating the microvasculature of the brain. This is particularly important in tumours, where the reliance on angiogenesis (new vessel formation) is crucial for tumour growth, and the resulting microvascular configuration and derangement has profound implications for diagnosis, treatment and monitoring. In addition, novel therapeutic approaches that seek to directly modify the microvasculature require more sensitive and specific biological markers of baseline...Keywords
This publication has 160 references indexed in Scilit:
- Imaging of integrin αvβ3 expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomographyNeuro-Oncology, 2009
- 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed gliomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusionJournal of Magnetic Resonance Imaging, 2007
- Distinction Between Recurrent Glioma and Radiation Injury Using Magnetic Resonance Spectroscopy in Combination With Diffusion-Weighted ImagingInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agentsBritish Journal of Cancer, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Cerebral blood volume, genotype and chemosensitivity in oligodendroglial tumoursNeuroradiology, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Computer-assisted analysis of the microvasculature in untreated glioblastomasJournal of Neuro-Oncology, 1995
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971